RGC
LLY icon

Roberts, Glore & Co’s Eli Lilly LLY Stock Holding History

Roberts, Glore & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$687K Sell
573
-19
-3% -$19.4K 0.17% 117
2026
Q1 		$545K Sell
592
-1
-0.2% -$1.01K 0.15% 125
2025
Q4 		$637K Sell
593
-35
-6% -$33.5K 0.17% 116
2025
Q3 		$479K Buy
628
+7
+1% +$5.21K 0.13% 138
2025
Q2 		$484K Hold
621
– – 0.14% 132
2025
Q1 		$513K Buy
621
+13
+2% +$10.8K 0.16% 123
2024
Q4 		$469K Sell
608
-5
-0.8% -$4.14K 0.14% 126
2024
Q3 		$543K Sell
613
-2
-0.3% -$1.8K 0.16% 121
2024
Q2 		$557K Sell
615
-10
-2% -$8K 0.17% 116
2024
Q1 		$486K Sell
625
-2
-0.3% -$1.42K 0.15% 120
2023
Q4 		$365K Buy
627
+30
+5% +$17.5K 0.11% 136
2023
Q3 		$321K Buy
597
+25
+4% +$12.9K 0.11% 148
2023
Q2 		$268K Sell
572
-20
-3% -$8.39K 0.09% 170
2023
Q1 		$203K Buy
+592
New +$200K 0.07% 194
2022
Q1 		– Sell
-735
Closed -$203K – 208
2021
Q4 		$203K Buy
+735
New +$186K 0.05% 202

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Roberts, Glore & Co's LLY Position: Q2 2026 in Review

Roberts, Glore & Co reduced its Eli Lilly (LLY) stake by 3.2% in Q2 2026, selling an estimated $19.4K and leaving 573 shares worth $687K. The position accounts for 0.17% of the portfolio, ranked #117.

Roberts, Glore & Co first reported a position in LLY in Q4 2021 and has held it in 15 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Roberts, Glore & Co held 573 shares of Eli Lilly worth $687K as of Q2 2026.
  • Roberts, Glore & Co sold 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.17% of Roberts, Glore & Co's portfolio in Q2 2026, its #117 holding.
  • Roberts, Glore & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 15 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.